Mu-Hsuan Yang

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Mu-Hsuan Yang is an author at Golden Biotech (Taiwan) specializing in tumor microenvironment, immune checkpoint blockade combinations, and checkpoint inhibitor combinations.

Publications per year

2022–2022

Publications

CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor

Jia-Shiong Chen, Cheng-Han Chou, Yi-Hong Wu et al. · Scientific Reports · 2022 · 17 citations · Full text

Medicine, Cancer Biology, Immunology +17

Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice

Jia-Shiong Chen, Yi-Chien Hsieh, Cheng-Han Chou et al. · International Journal of Molecular Sciences · 2022 · 16 citations · Full text

Medicine, Immunology, Oncology +17

1–2 of 2